Houston Health Ventures
12647 Memorial Dr, Houston, TX, 77024, US
Overview
HHV is a seed-stage healthcare investment fund focused on Health IT, and they power the NextHIT Accelerator Program. They nurture tech talent for healthcare. (Deadline to register is August 25th. The event starts on August 28th).
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Finance
- Health Care
- Health Diagnostics
- Information Technology
- Medical
- Venture Capital
Investment portfolio
- MyLabBox
Participated · Equity · Dec 2015
myLAB Box operates a nationwide at-home STD screening platform with tests validated by fully licensed CLIA-certified lab affiliates experienced in infectious disease testing. The company offers a comprehensive selection of STD tests, including Chlamydia, Gonorrhea, HIV, Herpes, Syphilis and HPV. Kits are priced from $79 to $499 and are available via the company website and retail partners Amazon, Target and Walmart. Founded in 2013 by CEO Lora Ivanova and based in Los Angeles, the startup has raised $2.1M in total funding. myLAB Box says it will use the new capital to expand product offerings and increase access to its services. myLAB Box provides an online program and mail-order at-home STD test kits allowing consumers to screen for sexually transmitted diseases without visiting a clinic. Kits are tailored to individual lifestyles, arrive in discreet packaging with free delivery, include five-minute tests, and deliver lab-certified results. The service also offers access to professional STD counselors. Founded in 2013 by CEO Ursula Hessenflow and based in Los Angeles, the company intends to expand services nationwide to offer screening for HIV, chlamydia, gonorrhea and trichomoniasis. In November 2015 it secured $560K in angel funding to support that expansion. The company is preparing to raise a Series A round in 2016.
Team
No current team members are available.